🕒 Last update: loading…16/11/2026

Stock Clover Health Investments, Corp. CLOV

Clover Health Investments, Corp. — Investlytic score 2/5 on the five criteria.

-
-
40/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 2/5 criteria met. Data as of 01/11/2026.

  • ❌ Price trend failed
  • ⚠️ Mixed growth
  • ✅ Debt passed
  • ❌ P/E failed
  • ✅ Correction passed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2020 → 2021: -77.82%

Price change 2021 → 2022: -75.01%

Price change 2022 → 2023: 2.43%

Price change 2023 → 2024: 230.85%

Price change 2024 → 2025: -25.40%

Price change 2025 → 2026: 87.02%

Price change 2026 (year to date): 82.37%

Financial growth

Revenue CAGR (8 years): 31.63%

Earnings CAGR (8 years): N/A

Growth status: positive trend (>1%/yr) in revenue, earnings data insufficient/N/A.

Debt

Debt-to-equity ratio: 0.00

Debt/equity < 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 103.66

P/E > 25.0 (maximum threshold).

Correction (6 months)

Current correction: 18.76% from the high over 6 months.

Correction between 10.0% and 20.0% (target range).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Clover Health Investments, Corp.113.00.00+31.6 %🔒
Pediatrix Medical Group, Inc.14.00.76+2.1 %–
Addus HomeCare Corporation18.60.19+11.7 %★ 4/5
Vir Biotechnology, Inc.–0.24+115.2 %–
Fleury S.A.16.31.05+16.2 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Key reported figures

Revenue, net income and net margin reported by Clover Health Investments, Corp. over the latest fiscal years.

Revenue
1.9 bn USD
fiscal year 2025
Net income
-85.5 m USD
fiscal year 2025
Net margin
-4.5 %
fiscal year 2025
Average annual growth
+23.4 %
Revenue growth over 5 years
Market cap
2.6 bn USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
2020673 m-136 m-20.3 %n/a
20211.5 bn-588 m-39.9 %+118.8 %
20221.1 bn-340 m-31.0 %-25.5 %
20231.3 bn-213 m-16.9 %+15.0 %
20241.4 bn-43.0 m-3.1 %+8.8 %
20251.9 bn-85.5 m-4.5 %+40.3 %

Amounts converted to USD. Source: published annual accounts, collected on 13/11/2026.

+

Accounts and financial health

Balance sheet and cash flow published by Clover Health Investments, Corp. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).

Overview
solid accounts
according to Altman Z, Piotroski and net debt
Altman Z-score
4.14
safe zone (above 2.99)
Piotroski Score
6 / 9
4 to 6: average accounts
Net Debt / EBITDA
-18.41 x
net cash
Fiscal year20212022202320242025
Cash and investments615 m335 m236 m222 m95.3 m
Total Debt27.8 m5.9 m4.7 m00
Net Debt-272 m-97.9 m-112 m-195 m-78.3 m
Equity535 m357 m286 m341 m309 m
Total assets951 m809 m571 m581 m541 m
Operating cash flow-282 m-204 m-116 m34.8 m-66.9 m
Investments (capex)723,0004.5 m584,0001.6 m2.0 m
Free cash-flow-283 m-208 m-116 m33.3 m-69.0 m
Share buybacks147,0006.4 m6.2 m18.3 m55.2 m
Dividends paid00000

Amounts in USD, currency of the published accounts.

Trailing 12-month ratios

Price / earnings (P/E)287.06 x
Price / book value6.64 x
Return on Equity (ROE)3.5 %
Return on Invested Capital (ROIC)3.0 %
Net margin0.5 %
Debt / equity0.00 x
Current ratio1.55 x
Free cash-flow yield5.1 %

Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 16/11/2026.

+

Valuation and competitors

Clover Health Investments, Corp. compared with its sector on the same exchange and with its main competitors.

Company P/E
116.3
459.0 % above the sector
Sector median P/E
20.8
healthcare, Nasdaq
Sector over 10 years
28.2
10-year median, range 20.4 to 45.8

Direct competitors

CompanyMarket cap (USD)P/ENet margin
Clover Health Investments, Corp.2.6 bn113.0-4.5 %
Oscar Health, Inc. OSCR7.9 bn21.9-3.8 %
Alignment Healthcare, Inc. ALHC1.5 bn56.5-0.0 %
Centene Corporation CNC34.5 bn27.7-3.4 %
Humana Inc. HUM52.1 bn27.40.9 %
CVS Health Corporation CVS107 bn10.70.4 %
Cigna Corporation CI77.6 bn9.52.2 %
Sector median (Nasdaq)20.8

Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 13/11/2026. Competitors: comparable companies named by the data provider.

+

Analyst consensus and forecasts

What the financial analysts covering Clover Health Investments, Corp. publish: ratings, price targets and earnings forecasts.

Majority rating
hold
9 analysts

Breakdown of ratings

strong buy 0buy 1hold 5sell 3strong sell 0

Price targets: published for companies listed in the United States only.

Track record against expectations: reported EPS above consensus 8 times over the last 12 releases.

Source: ratings and forecasts published by analysts, collected on 14/11/2026. An analyst rating or target is not a guarantee.

+

Who owns the stock

Free float, institutional investors, large funds, executives and elected officials: declared positions in Clover Health Investments, Corp.

Free float
77.3 %
share of freely traded shares
Large funds tracked
20
hold the stock as of 2026Q2
Executives (insiders)
0 / 25
0 purchases, 25 sales in 130 days

Large funds tracked

FundSharesValue (USD)Weight in the fundChangeQuarter
BlackRock35.1 m184 m0.0 %+10.3 %2026Q2
State Street20.4 m107 m0.0 %+113.0 %2026Q2
Geode Capital Management10.8 m56.8 m0.0 %+7.9 %2026Q2
Vanguard Group23.5 m55.2 m0.0 %+1.8 %2025Q4
Citadel Advisors4.3 m22.7 m0.0 %+130.4 %2026Q2
Northern Trust3.8 m19.8 m0.0 %+14.1 %2026Q2
Renaissance Technologies2.8 m14.7 m0.0 %-17.5 %2026Q2
Morgan Stanley2.3 m12.0 m0.0 %+4.9 %2026Q2

Latest insider transactions

DatePersonSideAmount
20/10/2026Soares Karensale89,822 USD
19/10/2026Reynoso Jamie L.sale17,931 USD
15/10/2026Toy Andrewsale290,984 USD
15/10/2026Soares Karensale68,670 USD
15/10/2026Thornton Joseph Claysale21,486 USD
15/10/2026Wai Conradsale110,574 USD

Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 16/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
Nasdaq
IPO: 12/06/2020
ISIN code
US18914F1030
Workforce
570
full-time employees
Chief executive
Andrew Toy

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Clover Health Investments, Corp.

What is the Clover Health Investments, Corp. share price?

Latest recorded price: 4.96 USD on 13/11/2026, for a market cap of 2.6 bn USD.

What is the revenue of Clover Health Investments, Corp.?

1.9 bn USD for fiscal year 2025, with net income of -85.5 m USD (net margin -4.5 %).

What do analysts say about Clover Health Investments, Corp.?

Out of 9 analysts: 1 buy or strong buy, 5 hold, 3 sell or strong sell.

What is the P/E ratio of Clover Health Investments, Corp.?

Trailing 12-month P/E of 116.3, against 20.8 for the sector median on the same exchange (10-year median: 28.2).

Is Clover Health Investments, Corp. stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN US18914F1030).

How many employees does Clover Health Investments, Corp. have?

570 full-time employees according to the latest published profile.

Who runs Clover Health Investments, Corp.?

Andrew Toy is the company's chief executive.

Which large funds own Clover Health Investments, Corp.?

As of 2026Q2, among the large funds tracked: BlackRock, State Street, Geode Capital Management, Vanguard Group, Citadel Advisors.

07

Similar stocks